Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Cacace

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Biochemical Society Transactions|July 9, 2026
Nitroxoline revisited: antibacterial mechanisms, spectrum, and therapeutic potential of an old drug in the era of antimicrobial resistanceElisabetta Cacace, Stephan Göttig
Current Opinion in Systems Biology|July 28, 2020
Chemical genetics in drug discoveryElisabetta Cacace, George Kritikos, Athanasios Typas
Current Topics in Developmental Biology|May 27, 2020
Logical modeling of cell fate specification-Application to T cell commitmentElisabetta Cacace, Samuel Collombet, Denis Thieffry
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 12, 2024
Emergence of OXA-48-like producing <i>Citrobacter</i> species, Germany, 2011 to 2022Julian Sommer, Hannah Reiter, Janko Sattler, et al.
Nature Microbiology|December 2, 2024
Systematic mapping of antibiotic cross-resistance and collateral sensitivity with chemical geneticsNazgul Sakenova, Elisabetta Cacace, Askarbek Orakov, et al.
Molecular Systems Biology|June 17, 2025
AlphaDesign: a de novo protein design framework based on AlphaFoldMichael A Jendrusch, Alessio L J Yang, Elisabetta Cacace, et al.
Nature Microbiology|April 23, 2026
In silico typing maps the natural diversity of Escherichia coli transporter-dependent capsulesSamuel Miravet-Verde, Elisabetta Cacace, Carine Roese Mores, et al.
Nature Microbiology|September 28, 2023
Systematic analysis of drug combinations against Gram-positive bacteriaElisabetta Cacace, Vladislav Kim, Vallo Varik, et al.
Nature Communications|April 22, 2025
Uncovering nitroxoline activity spectrum, mode of action and resistance across Gram-negative bacteriaElisabetta Cacace, Manuela Tietgen, Meike Steinhauer, et al.
Nature|October 14, 2021
Unravelling the collateral damage of antibiotics on gut bacteriaLisa Maier, Camille V Goemans, Jakob Wirbel, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biochemical Society Transactions|July 9, 2026
Nitroxoline revisited: antibacterial mechanisms, spectrum, and therapeutic potential of an old drug in the era of antimicrobial resistanceElisabetta Cacace, Stephan Göttig
Current Opinion in Systems Biology|July 28, 2020
Chemical genetics in drug discoveryElisabetta Cacace, George Kritikos, Athanasios Typas
Current Topics in Developmental Biology|May 27, 2020
Logical modeling of cell fate specification-Application to T cell commitmentElisabetta Cacace, Samuel Collombet, Denis Thieffry
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 12, 2024
Emergence of OXA-48-like producing <i>Citrobacter</i> species, Germany, 2011 to 2022Julian Sommer, Hannah Reiter, Janko Sattler, et al.
Nature Microbiology|December 2, 2024
Systematic mapping of antibiotic cross-resistance and collateral sensitivity with chemical geneticsNazgul Sakenova, Elisabetta Cacace, Askarbek Orakov, et al.
Molecular Systems Biology|June 17, 2025
AlphaDesign: a de novo protein design framework based on AlphaFoldMichael A Jendrusch, Alessio L J Yang, Elisabetta Cacace, et al.
Nature Microbiology|April 23, 2026
In silico typing maps the natural diversity of Escherichia coli transporter-dependent capsulesSamuel Miravet-Verde, Elisabetta Cacace, Carine Roese Mores, et al.
Nature Microbiology|September 28, 2023
Systematic analysis of drug combinations against Gram-positive bacteriaElisabetta Cacace, Vladislav Kim, Vallo Varik, et al.
Nature Communications|April 22, 2025
Uncovering nitroxoline activity spectrum, mode of action and resistance across Gram-negative bacteriaElisabetta Cacace, Manuela Tietgen, Meike Steinhauer, et al.
Nature|October 14, 2021
Unravelling the collateral damage of antibiotics on gut bacteriaLisa Maier, Camille V Goemans, Jakob Wirbel, et al.
Pageof 1